IC-261 | Interleukin Related interleukin-related.com

Product Name :
IC-261

Search keywords :
IC261

drugId :
null

Target Vo:
Casein kinase I isoform epsilon

Target Vo Short Name :
CSNK1E

Moa_Name:
Casein kinase I isoform epsilon inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Dundee

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD80 Antibody (YA3386)
S100A10 Antibody (YA675)
Cyclin D2 Antibody (YA789): Cyclin D2 Antibody (YA789) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to Cyclin D2 (6E11). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts